• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时间自 SARS-CoV-2 疫苗接种、年龄、性别和合并症对住院 SARS-CoV-2 感染患者 COVID-19 结局的影响。

The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection.

机构信息

University Unit of Hygiene, Epidemiology and Public Health, University of Brescia, 25123 Brescia, Italy.

Neurology Unit, Department of Continuity of Care and Frailty, ASST Spedali Civili Hospital, Brescia, Italy; Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Italy.

出版信息

Vaccine. 2024 Mar 19;42(8):1863-1867. doi: 10.1016/j.vaccine.2024.02.003. Epub 2024 Feb 14.

DOI:10.1016/j.vaccine.2024.02.003
PMID:38355322
Abstract

We evaluated the impact of COVID-19 vaccination on disease outcome in hospitalized patients with SARS-CoV-2 infection with a prospective study. 745 vaccinated and 451 unvaccinated patients consecutively admitted to a COVID-19 Hospital from 1st September 2021 to 1st September 2022 were included. Compared with unvaccinated cases, vaccinated patients were older, had more comorbidities, but had a lower risk of O2 need (odds ratio, OR, 0.46; 95 % CI 0.32-0.65) by logistic regression analysis adjusted for age, sex, comorbidity and WHO COVID-19 Clinical Progression Scale at admission. The ORs for O2 need were 0.38 (0.24-0.61), 0.50 (0.30-0.83) and 0.57 (0.34-0.96) in patients vaccinated 14-120, 121-180 and > 180 days prior to hospitalization, respectively. An anti-spike Ig titer higher than 5000 U/ml was associated with a reduced risk of O2 need (OR 0.52; 95 % CI 0.30-0.92). This study shows that COVID-19 vaccination has a significant impact on COVID-19 outcomes in hospitalized patients.

摘要

我们通过一项前瞻性研究评估了 COVID-19 疫苗接种对住院 SARS-CoV-2 感染患者疾病结局的影响。该研究纳入了 2021 年 9 月 1 日至 2022 年 9 月 1 日期间连续收治于 COVID-19 医院的 745 名接种疫苗和 451 名未接种疫苗的患者。与未接种疫苗的病例相比,接种疫苗的患者年龄更大,合并症更多,但通过调整年龄、性别、合并症和入院时的世卫组织 COVID-19 临床进展量表后, logistic 回归分析显示,他们需要吸氧的风险较低(比值比,OR,0.46;95%CI,0.32-0.65)。在接种疫苗 14-120、121-180 和>180 天前住院的患者中,需要吸氧的 OR 分别为 0.38(0.24-0.61)、0.50(0.30-0.83)和 0.57(0.34-0.96)。抗刺突 IgG 滴度高于 5000 U/ml 与降低需要吸氧的风险相关(OR 0.52;95%CI,0.30-0.92)。这项研究表明,COVID-19 疫苗接种对住院患者的 COVID-19 结局有显著影响。

相似文献

1
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection.时间自 SARS-CoV-2 疫苗接种、年龄、性别和合并症对住院 SARS-CoV-2 感染患者 COVID-19 结局的影响。
Vaccine. 2024 Mar 19;42(8):1863-1867. doi: 10.1016/j.vaccine.2024.02.003. Epub 2024 Feb 14.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
4
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.新冠疫苗对降低真实世界中长新冠风险的效果:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Sep 29;19(19):12422. doi: 10.3390/ijerph191912422.
5
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
6
A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients.一项关于 COVID-19 疫苗接种者和未接种者中早期抗生素使用的回顾性队列研究。
J Med Virol. 2024 Mar;96(3):e29507. doi: 10.1002/jmv.29507.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.自加强疫苗接种以来的时间与新冠病毒相关哮喘加重的新冠病毒疾病严重程度及风险:来自英国COVIDENCE研究数据的纵向分析
BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158.
9
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
10
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.在有和没有先前 SARS-CoV-2 感染的人群中,COVID-19 mRNA 疫苗加强针接种后和 COVID-19 后心肌炎和心包炎的风险:在英国的一项自身对照病例系列分析。
PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.